ADGM Stock Forecast 2025-2026
Distance to ADGM Price Targets
ADGM Price Momentum
10 Quality Stocks Worth Considering Now
Researching Adagio Medical (ADGM) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ADGM and similar high-potential opportunities.
Latest ADGM Stock Price Targets & Analyst Predictions
Comprehensive analyst forecasts are currently unavailable for ADGM. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ADGM Analyst Ratings
ADGM Price Target Range
Latest ADGM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ADGM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Adagio Medical Holdings Inc. (ADGM) Competitors
The following stocks are similar to Adagio Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Adagio Medical Holdings Inc. (ADGM) Financial Data
Adagio Medical Holdings Inc. has a market capitalization of $26.12M with a P/E ratio of -0.6x. The company generates $602,000 in trailing twelve-month revenue with a -335.3% profit margin.
Revenue growth is +75.6% quarter-over-quarter, while maintaining an operating margin of -6,462.0% and return on equity of +28.6%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Adagio Medical Holdings Inc. (ADGM) Business Model
About Adagio Medical Holdings Inc.
Develops innovative solutions for cardiac arrhythmias.
Adagio Medical Holdings generates revenue by creating advanced medical equipment and systems, particularly focused on cryoablation technology to treat heart rhythm disorders. The company collaborates with healthcare professionals to deliver solutions that meet clinical needs and regulatory standards, ensuring its products are both effective and compliant.
As a key player in the medical technology sector, Adagio is positioned to capitalize on the growing demand for innovative cardiac care solutions, especially given the aging global population and the rising prevalence of cardiac disorders. By promoting minimally invasive techniques, the company aims to improve patient outcomes and quality of life.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
80
CEO
Mr. Todd Usen
Country
United States
IPO Year
2024
Website
adagiomedical.comAdagio Medical Holdings Inc. (ADGM) Latest News & Analysis
Adagio Medical Holdings, Inc. received FDA Breakthrough Device designation for its vCLASTM Cryoablation System, aimed at treating drug-refractory recurrent ventricular tachycardia.
Adagio's Breakthrough Device designation for its vCLAS™ system enhances its competitive edge, potentially leading to increased market share and revenue, positively impacting stock performance.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) reported Q4 2024 revenue of $137K, up from $78K in Q4 2023. Full-year revenue reached $0.6M, compared to $0.3M in the previous year.
Adagio Medical's revenue growth signals improving business performance, which may boost investor confidence and interest in its stock.
Adagio Medical (Nasdaq: ADGM) has appointed Deborah Kaster as Chief Business Officer. Kaster has over 25 years of experience in medical technology, focusing on strategy and corporate finance.
The appointment of Deborah Kaster as CBO signals potential strategic growth and enhanced investor relations for Adagio Medical, which could positively impact stock performance.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is focusing on ventricular tachycardia solutions and will present at the 2025 European Heart Rhythm Association Annual Meeting in Vienna.
Adagio Medical's focus on ventricular tachycardia solutions and participation in a major industry event signals potential growth and innovation, impacting investor confidence and stock performance.
Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation
1 month agoAdagio Medical Holdings, Inc. announced a corporate restructuring to focus on its FULCRUM-VT clinical trial and new product design optimization, following a strategic review.
Adagio Medical's restructuring to focus on clinical trials and product optimization indicates a strategic pivot that could enhance its market position and growth potential, impacting investor sentiment.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) will participate in TD Cowen's Health Care Conference on March 4, 2025, in Boston, focusing on catheter ablation technologies for cardiac arrhythmias.
Adagio Medical's presence at a major health care conference signals potential growth opportunities and investor interest in its innovative cardiac treatment technologies, impacting stock performance.
Frequently Asked Questions About ADGM Stock
What is Adagio Medical Holdings Inc.'s (ADGM) stock forecast for 2025?
Analyst forecasts for Adagio Medical Holdings Inc. (ADGM) are not currently available. The stock is trading at $1.78.
Is ADGM stock a good investment in 2025?
Analyst ratings for ADGM are not currently available. The stock is currently trading at $1.78. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ADGM stock?
Price predictions from Wall Street analysts for ADGM are not currently available. The stock is trading at $1.78.
What is Adagio Medical Holdings Inc.'s business model?
Adagio Medical Holdings generates revenue by creating advanced medical equipment and systems, particularly focused on cryoablation technology to treat heart rhythm disorders. The company collaborates with healthcare professionals to deliver solutions that meet clinical needs and regulatory standards, ensuring its products are both effective and compliant.
What is the highest forecasted price for ADGM Adagio Medical Holdings Inc.?
Price targets from Wall Street analysts for ADGM are not currently available. The stock is trading at $1.78.
What is the lowest forecasted price for ADGM Adagio Medical Holdings Inc.?
Price targets from Wall Street analysts for ADGM are not currently available. The stock is trading at $1.78.
What is the overall ADGM consensus from analysts for Adagio Medical Holdings Inc.?
Analyst ratings for ADGM are not currently available. The stock is trading at $1.78.
How accurate are ADGM stock price projections?
Stock price projections, including those for Adagio Medical Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.